Biologic Therapies Improve Work Outcomes in Spondyloarthritis

By Jack Cush, MD | 14 September 2018

A study from the British Society for Rheumatology Biologics Register in Axial Spondyloarthritis (BSRBR-AS) shows that biologic use significantly improves work productivity and overall activity impairment.

The BSRBR-AS registry analyzed 577 participants who were employed; 28% were started on biological therapy .

After 12-months of follow-up, those receiving biologic therapy had significantly greater improvements (relative to non-biological therapy) in presenteeism, overall work impairment, and overall activity impairment; however there was no difference in absenteeism.

There is consistent evidence that treatment with biological therapy improves these work and activity measures.

Disclosures:

The author has no conflicts of interest to disclose related to this subject

Add new comment

If you are a health practitioner, you may Login/Register to comment.

More Like This

BMS Tyk 2 Inhibitor Benefits Psoriasis

By Jack Cush, MD | 12 Sep 2018

The NEJM reports that an oral selecive Tyrosine kinase 2 (TYK2) inhibitor of TYK2 was shown to be superior to placebo in a 12 week trial in patients with active psoriasis.

[...]

Methotrexate's Low Efficacy in Cutaneous Psoriasis

By Jack Cush, MD | 06 Sep 2018

In a prospective, double-blind, randomized placebo-controlled study, Warren et al. studied the effect of an intensified methotrexate (MTX) in chronic plaque psoriasis and showed MTX to be effective and superior to placebo.

[...]

No Cancer Risk from Psoriatic Arthritis

By Jack Cush, MD | 30 Aug 2018

Inflammmation is a strong risk factor for malignancy. Yet there are mixed results on whether patients with psoriatic arthritis (PsAg) augments the incidence of cancer and all-cause and cause-mortality.

A study from the national British Society for Rheumatology Biologics Register examined the risk of cancer, assessed by standardized incidence ratios (SIRs) or standardized mortality ratios (SMRs).

[...]

Treatments Do Not Increase Infection Risk in Ankylosing Spondylitis

By Jack Cush, MD | 24 Aug 2018

A large Canadian study of the drug use in ankylosing spondylitis (AS) demonstrated no evidence that the risk of serious, hospitalized infection was influenced by the use of DMARD and/or of tumour necrosis factor inhibitors (TNFi) therapy.

They studied 747 AS patients who initiated TNFI and/or DMARDs between 2001 and 2011 to identify hospitalized infection coding data and hospital discharge diagnoses.

[...]

Dietary Recommendations for Psoriatic Disease

By Jack Cush, MD | 21 Aug 2018

A systematic review by the Medical Board of the National Psoriasis Foundation examined the role of diet in managing adult patients with psoriasis and/or psoriatic arthritis and suggest that dietary interventions to reduce disease severity.

A metanalysis of 55 studies and 4534 patients with psoriasis examined the role of weight loss, gluten-free diets, vitamin supplementation on reducing psoriatic disease activity.

[...]

Search form

You are here